Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Accolade (DE:4NE1)
FRANKFURT:4NE1
Accolade (4NE1) Stock Price & Analysis
0 Followers
4NE1 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€6.05 - €14.40
Previous Close€8.55
Volume0.00
Average Volume (3M)N/A
Market Cap
€675.74M
Enterprise Value€686.69M
Total Cash (Recent Filing)$230.02M
Total Debt (Recent Filing)$241.70M
Price to Earnings (P/E)N/A
Beta1.06
Next Earnings
Apr 25, 2024EPS Estimate
-€0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding77,407,607
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-39.56
Price to Sales (P/S)6.68
Price to Cash Flow (P/CF)34.20
P/FCF Ratio119.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.77
Enterprise Value/Gross Profit4.18
Enterprise Value/Ebitda-9.58
Forecast
1Y Price Target
€12.76Price Target Upside49.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
Accolade News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAccolade is on the tipping point of hitting revenue growth and profitability goals through natural leverage and targeted cost cuts.
Market Demand And Revenue VisibilityEnd Market Demand Appears Strong with management noting plenty of opportunity and ability to offer cost trends bending.
Product Expansion And Customer Base GrowthAccolade's acquisitions have expanded its customer base and service offerings, enhancing cross-selling opportunities.
Bears Say
Customer RetentionRecent reports show a decline in gross retention, raising concerns about the company's ability to maintain its current growth trajectory.
Debt ObligationsThe company's convertible loan due in April places limitations on its ability to engage in mergers and acquisitions, despite having the means to settle the debt.
Operating EnvironmentThe operating environment may pose challenges to future financial estimations, potentially impacting the stock's performance.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
9.61% Other Institutional Investors
90.39% Public Companies and
Individual Investors
4NE1 FAQ
What was Accolade’s price range in the past 12 months?
Accolade lowest stock price was €6.05 and its highest was €14.40 in the past 12 months.
What is Accolade’s market cap?
Currently, no data Available
When is Accolade’s upcoming earnings report date?
Accolade’s upcoming earnings report date is Apr 25, 2024 which is today.
How were Accolade’s earnings last quarter?
Accolade released its earnings results on Jan 08, 2024. The company reported -€0.263 earnings per share for the quarter, beating the consensus estimate of -€0.419 by €0.157.
Is Accolade overvalued?
According to Wall Street analysts Accolade’s price is currently Undervalued.
Does Accolade pay dividends?
Accolade does not currently pay dividends.
What is Accolade’s EPS estimate?
Accolade’s EPS estimate is -€0.11.
How many shares outstanding does Accolade have?
Currently, no data Available
What happened to Accolade’s price movement after its last earnings report?
Accolade reported an EPS of -€0.263 in its last earnings report, beating expectations of -€0.419. Following the earnings report the stock price went up 5.941%.
Which hedge fund is a major shareholder of Accolade?
Among the largest hedge funds holding Accolade’s share is ARK Investment Management LLC. It holds Accolade’s shares valued at 82M.
---
Accolade Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€12.76 (49.27% Upside)
€12.76 (49.27% Upside)
Blogger Sentiment
Bullish
DE:4NE1 Sentiment 75%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.67%
12-Months-Change
Fundamentals
Return on Equity
-26.66%
Trailing 12-Months
Asset Growth
-14.04%
Trailing 12-Months
Company Description
Accolade
Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. it generates revenue through providing personalized health guidance solutions to members.
---
4NE1 Company Deck
---
4NE1 Earnings Call
Q3 2024
0:00 / 0:00
---
4NE1 Stock 12 Months Forecast
Average Price Target
€12.76
▲(49.27% Upside)
Technical Analysis
Accolade
―
Aclaris Therapeutics
―
Acadia Healthcare
―
Achieve Life Sciences
―
ACADIA Pharmaceuticals
―
Best Analysts Covering 4NE1
1 Year
1 Year Success Rate
6/16 ratings generated profit
1 Year Average Return
-10.08%
reiterated a buy rating 3 months ago
Copying Ryan MacDonald's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -10.08% per trade.
---